InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
3.380
-0.080 (-2.31%)
At close: Jun 27, 2025, 4:00 PM
3.200
-0.180 (-5.33%)
After-hours: Jun 27, 2025, 7:59 PM EDT
InMed Pharmaceuticals Employees
InMed Pharmaceuticals had 13 employees as of June 30, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,538
Profits / Employee
-$639,346
Market Cap
4.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
INM News
- 1 day ago - InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules - Newsfile Corp
- 3 days ago - InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - Newsfile Corp
- 4 days ago - InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study - Newsfile Corp
- 14 days ago - InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA - Newsfile Corp
- 6 weeks ago - InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 4 months ago - InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update - Newsfile Corp
- 5 months ago - InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration - Newsfile Corp
- 5 months ago - InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds - Newsfile Corp